Avisi Technologies Announces $10.7M Capital Raise to Advance Novel Glaucoma Device Development
REDWOOD CITY, Calif., Feb. 25, 2026 /PRNewswire/ — Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the closing of $10.7M in new financing. The Series A round was led by MedVenture Partners, with participation from new investors Sherpa Healthcare Partners, SNBL-Gemseki, SBI US Gateway Fund, Golden Seeds, and OneOneFive. This financing round had strong participation from existing investors, including Good Growth Capital, Accanto Partners, Life Sciences Greenhouse Investment, and Quaker Capital Investments.
